Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

Share Price is delayed by 15 minutes
Get Live Data
13.50    0.00 (0.00%)
Bid:
13.25
Ask:
13.75
Spread: 0.50 (3.774%)
Market Cap: £65.58m
CREO Live PriceLast checked at - London Stock Exchange

Intraday Creo Medical Share Chart

Exercise of Options

12 Nov 2007 15:39

China Real Estate Opportunities Ltd12 November 2007 CHINA REAL ESTATE OPPORTUNITIES LIMITED Exercise of Options China Real Estate Opportunities Limited ("CREO" or the "Company") announces thatit has received notice of exercise in respect of options over 200,000 newordinary shares of 1p each ('Ordinary Shares') held by Robert Tincknell, adirector of the Company. The board of the Company has resolved to allow MrTincknell to exercise these options in advance of their stated first exercisedate of 1 February 2008.Application has been made for the new Ordinary Shares to be admitted to tradingon AIM and dealings are expected to commence in the week beginning 19 November2007. The new Ordinary Shares will rank pari passu with the existing OrdinaryShares in issue and increase the number of shares in issue to 50,676,185.Following the exercise of these options, Robert Tincknell's total holding in theCompany is 521,171 Ordinary Shares. Appointment Further to the announcement dated 8 August 2007, Richard David, ManagingDirector of Treasury Holdings China Limited ("THCL"), has assumed executiveresponsibility for THCL's operations in China.THC is the Company's investment manager and has over 40 full time professionalstaff based in Shanghai and Beijing.Richard David joined THCL from Macquarie Bank Limited, where he was managingdirector of Macquarie Real Estate Capital China. Richard has since 1999 overseenthe operations of Macquarie China, including several business units operatingwithin the real estate sector across China. Richard has extensive experience inall facets of transactional activity and in real estate development, assetacquisitions, finance, tax, corporate structures and investor relations. Robert Tincknell, who has been a key driver of the growth of Treasury Holdingsand CREO in China over the past three years, is returning to the UK to becomeManaging Director of both Treasury's UK and International Divisions, the latterencompassing Treasury's operations in Russia, Sweden, Germany and Spain. Enquiries to: CREORay Horney Tel: + 44 (0) 1273 775 225 Landsbanki Securities (UK) Limited Tel: + 44 (0) 20 7426 7736Paul FinchamJonathan BecherRobert Naylor Bankside Consultants Ltd Tel: + 44 (0) 20 7367 8888Simon RothschildOliver Winters Murray ConsultantsEd Micheau Tel: + 353 1 498 0300 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Jun 20267:00 amRNSAppointment of Nominated Adviser /Corporate Broker
4th Jun 20267:00 amRNSPosting of 2025 Annual Report and Notice of AGM
28th May 20262:35 pmRNSHolding(s) in Company
22nd May 202610:11 amRNSResult of Placing
22nd May 20267:02 amRNSProposed Placing to raise approximately £5.5m
22nd May 20267:01 amRNSFY25 Final Results
22nd May 20267:00 amRNSProposed Sale of 49% Interest in Creo Medical SL
7th May 20267:00 amRNS-RMicroBlate™ Fine commercial update
5th May 20267:00 amRNS-RSpydrBlade™ Flex used in novel BEAM procedures
30th Apr 20267:00 amRNS-RKOL presentations on Creo Core Products at DDW
29th Apr 20267:00 amRNS-RUK private hospital use Speedboat for cancer case
22nd Apr 20267:00 amRNSPositive Q1 trading update
16th Apr 20267:00 amRNSDisposal and outsourcing of manufacturing
24th Feb 20267:00 amRNSAppointment of Joint Corporate Broker
20th Jan 20267:00 amRNSFY25 Trading Update
14th Jan 20267:00 amRNSAward of Shares under Share Incentive Plan
27th Oct 20257:00 amRNSNotice of Capital Markets Day
7th Oct 202511:37 amRNSCapital Markets Day update
22nd Sep 20257:00 amRNSUnaudited results for the six months ended 30 June
12th Sep 20253:14 pmRNSHolding(s) in Company
11th Sep 20257:00 amRNSNotice of Results
12th Aug 20254:56 pmRNSDirector/PDMR Share Dealing
4th Aug 20257:00 amRNS-RSpeedboat® patient testimonial
24th Jul 20257:00 amRNSAward of Shares under SIP and Director Dealings
21st Jul 20257:00 amRNSH1’25 Trading Update
10th Jul 20257:00 amRNS-RMicroBlate™ Flex begins lung tumour clinical study
9th Jul 20259:41 amRNSPDMR Options Revision
30th Jun 20257:00 amRNSChange of Nominated Adviser
26th Jun 202511:08 amRNSResult of AGM
26th Jun 20257:00 amRNSAGM Statement and Directorate Changes
11th Jun 20257:00 amRNS-RU.S. FDA clearance for SpydrBlade™ Flex
2nd Jun 20257:00 amRNSDirector/PDMR Shareholding
30th May 20257:00 amRNSPosting of AR&R and Notice of AGM
28th May 20257:00 amRNSUS Reimbursement milestone for Speedboat procedure
27th May 202512:48 pmRNSHolding(s) in Company
23rd May 20254:25 pmRNSHolding(s) in Company
22nd May 20257:00 amRNSDirectorate changes
19th May 20257:00 amRNSFinal Results
6th May 20257:00 amRNSNotice of investor presentations
15th Apr 20252:00 pmRNSNotice of Results
1st Apr 20259:34 amRNSHolding(s) in Company
31st Mar 202512:17 pmRNSHolding(s) in Company
26th Mar 20257:00 amRNSGrant of Options
20th Mar 20257:00 amRNS-RUK & EU Commercial launch of SpydrBlade™ Flex
6th Mar 20257:00 amRNSAppointment of Nominated Adviser and sole Broker
17th Feb 20257:00 amRNSFY24 Trading Update
12th Feb 202511:00 amRNSCompletion of sale of 51% interest in subsidiary
6th Feb 20259:00 amRNS-RFirst Welsh adopter of Speedboat® technology
3rd Feb 20253:00 pmRNSTotal Voting Rights
21st Jan 20257:00 amRNSAward of Shares under Share Incentive Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.